摘要:
The disclosure provides a method for preparing nilotinib. The preparation method includes the following steps: performing an aminocarbonylation reaction on a compound A and 3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl) aniline to obtain an amination product; and performing deprotection treatment of an R group on the amination product to obtain the nilotinib, wherein the compound A has a structure shown in formula I, and in formula I, an R group is selected from benzyl, -COCF 3 , -CHO or -CO 2 R', where an R' group is C 1 ∼C 10 alkyl, C 1 ∼C 3 alkoxy ethyl or C 7 ∼C 19 aralkyl. The preparation method is short in synthesis route and mild in reaction condition. Moreover, with adoption of a special raw material, the preparation method may improve a yield of the nilotinib and simultaneously reduce process cost.
摘要翻译:本公开提供了制备尼罗替尼的方法。 该制备方法包括以下步骤:对化合物A和3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺进行氨基羰基化反应,得到胺化产物; 进行氨基化产物上R基的脱保护处理得到尼罗替尼,其中化合物A具有式I所示结构,式I中R基选自苄基,-COCF 3,-CHO或-CO 2 R ',其中R'基团为C1〜C10烷基,C1〜C3烷氧基乙基或C7〜C19芳烷基。 该制备方法合成路线短,反应条件温和。 而且,通过采用特殊的原料,该制备方法可以提高尼罗替尼的产量,同时降低加工成本。
摘要:
The present invention relates to a preparation method for a chiral intermediate for use in statins, acquired with chloroacetic acid and benzyl alcohol as starting materials via a series of reactions, namely etherification, condensation, substitution, and asymmetric reduction. The preparation method provided in the present invention has a novel route of synthesis, allows an intermediate compound to be introduced conveniently into the chiral center of a glycol via enzyme reduction, and not only is low in costs, but also is reliable in quality. The route of synthesis provided in the present invention uses raw materials of low costs, has an easy to operate process, and provides a final product of great purity and high yield.
摘要:
The invention discloses an ozonization continuous reaction device, comprising a raw material inlet, a raw material distributing device, one or plurality of single reaction tubes, a product outlet and an air vent. The first end of the raw material distributing device is communicated with the raw material inlet; the first end of one or plurality of single reaction tubes is communicated with the second end of the raw material distributing device; the product outlet is communicated with the second end of the single reaction tube; ozone is conveyed to the single reaction tube via the air vent. The ozonization continuous reaction device provided by the invention realizes the large-scale and continuous production of the ozonization reaction on the basis of guaranteeing security; as the single reaction tube is arranged, the ozone amount and the liquid raw material existing in the single reaction tube in unit time become fewer, the reaction security is greatly improved; in addition, the liquid raw material and the ozone are continuously fed into the reaction device, the exhaust gas and the products are continuously discharged from the reaction device, the accumulation of the ozone is prevented, the security is greatly guaranteed, and the production capacity also can be improved to a higher level.
摘要:
Disclosed are a ketoreductase mutant and a method for producing a chiral alcohol. The ketoreductase mutant has an amino acid sequence obtained by the mutation of the amino acid sequence shown in SEQ ID NO: 1, and the mutation includes a mutation siteK200H. In the present disclosure, the mutant obtained by mutation takes a ketone compound as a raw material, the chiral alcohol may be efficiently produced by stereoselective reduction, and the stability is greatly improved, which is suitable for popularization and application to the industrial production of the chiral alcohol.
摘要:
The invention provides a Diketoreductase (DKR) mutant, its nucleotide coding sequence, and an expression cassette, recombinant vector and host cell containing the sequence, as well as a method for application of the mutant to the preparation of 3R,5S-dicarbonyl compound. An ee value of the obtained 3R,5S-dicarbonyl compound is higher than 99%, and a de value is about 90%. The DKR mutant is a key pharmaceutical intermediate, and particularly provides an efficient catalyst for synthesis of a chiral dicarbonyl hexanoic acid chain of a statin drug.
摘要:
Provided are an intermediate compound for preparing rosuvastatin calcium and a preparation method of the rosuvastatin calcium. The method comprises: using the foregoing intermediate compound as a raw material, and subjecting the raw material to a step of Wittig reaction, a step of protecting group removal and hydrolysis and a step of calcium salt formation, so as to obtain the rosuvastatin calcium. The product, which is prepared from the intermediate compound, can be substantially enhanced in stereoselectivity and also notably improved in purity and yield; in addition, the method for preparing rosuvastatin calcium from the intermediate compound is simple, convenient and low in cost.